| ［1］ |
Toumi A, Yarrarapu SNS, Litaiem N. Wells syndrome［M/OL］. StatPearls. Treasure Island （FL）: StatPearls Publishing， 2023. https://www.ncbi.nlm.nih.gov/books/NBK532294/.
|
| ［2］ |
Alvarez Martinez D, Laffitte E. A non⁃infectious cellulitis to know: Wells' syndrome［J］. Rev Med Suisse, 2021,17（732）:610⁃614.
|
| ［3］ |
Räßler F, Lukács J, Elsner P. Treatment of eosinophilic cellulitis （Wells syndrome） ⁃ a systematic review［J］. J Eur Acad Dermatol Venereol, 2016,30（9）:1465⁃1479. doi: 10.1111/jdv.13706.
|
| ［4］ |
Coattrenec Y, Ibrahim Yasmine L, Harr T, et al. Long⁃term remission of Wells syndrome with omalizumab［J］. J Investig Allergol Clin Immunol, 2020,30（1）:58⁃59. doi: 10.18176/jiaci.0436.
|
| ［5］ |
Yeon J, Chan RC, Zagarella S. Eosinophilic cellulitis successfully treated with methotrexate［J］. Australas J Dermatol, 2020,61（4）:e421⁃e423. doi: 10.1111/ajd.13358.
|
| ［6］ |
Blomberg M, Winther C, Høyrup S, et al. Treatment of widespread eosinophilic cellulitis （Wells' syndrome） with benralizumab［J］. Acta Derm Venereol, 2020,100（18）:adv00332. doi: 10.2340/00015555⁃3697.
|
| ［7］ |
Lu J, Wu W, Zhang M, et al. Wells syndrome successfully treated with tripterygium glycosides［J］. Clin Cosmet Investig Dermatol, 2021,14:1029⁃1031. doi: 10.2147/CCID.S328578.
|
| ［8］ |
Kariyawasam HH. Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL⁃4 and IL⁃13 via IL⁃4Rα inhibition with dupilumab［J］. Expert Rev Clin Immunol, 2020,16（12）:1115⁃1125. doi: 10.1080/1744666X.2021.1847083.
|
